49 results on '"Victor E. Ortega"'
Search Results
2. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease
3. Spirometry in Mixed Race Civil War Veterans
4. Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease
5. Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary Disease
6. Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers
7. The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS
8. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
9. CT Texture Features Predict Severe COPD Exacerbations in SPIROMICS
10. Sex Differences in Longitudinal Assessment of COPD Morbidity in SPIROMICS
11. Secondhand Smoke Alters Alveolar Macrophage Gene Expression
12. Lung Structure and Risk of Sleep Apnea in SPIROMICS
13. Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort
14. Immune and Cytokine Dysfunction in Cystic Fibrosis
15. A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography
16. Prolonged, Physiologically Relevant Concentrations of Nicotine and Nicotine Metabolites in Airways of Smokers
17. Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort
18. Reduced Pneumococcal Antibody Function Is Associated with Exacerbations of COPD in SPIROMICS
19. Insights from Mid-Expiratory Flow Rate (FEF25-75%) in Ever-Smokers with Preserved Lung Function in the Subpopulations and Intermediate Markers in COPD Study (SPIROMICS) Cohort
20. Genome-Wide Association Study of Short-Acting Bronchodilator Response Identifies Novel Pharmacogenetic Loci in SPIROMICS
21. Patient-Reported Clinical Variables Associated with Significant Air Trapping in Smokers: An Analysis of the SPIROMICS Cohort
22. Deep Resequencing of the Beta-2 Adrenergic Receptor Gene (ADRB2) in COPD and Asthma Cohorts Identifies Functional Rare Variants
23. FEV1SVC Ratio Below 0.7 Is Associated with Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers with Normal Spirometry
24. Current Smoking Down-Regulates Specific Alveolar Macrophage Host Defense Gene Expression Pathways
25. Neutrophil to Lymphocyte Ratio (NLR) Is a Potential Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort
26. Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort
27. Resequencing to Fine Map Known Idiopathic Pulmonary Fibrosis Risk Genes. Homing in on Causal Variants
28. Picking the Right Fruit: Intersecting Chronic Obstructive Pulmonary Disease Genome-Wide Association Study Discoveries with Epigenetics
29. Reduced Maximum Mid-Expiratory Flow Is Independently Associated with Computed Tomography Measures of Smoking-Related Lung Disease in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) Cohort
30. Women with COPD Experience Increased Symptom Burden, Frequent and Severe Exacerbation, and Impaired Functional Capacity as compared to Men in SPIROMICS
31. Distinct Blood Biomarkers Associate with Visual Evidence of Interstitial Lung Abnormality on HRCT in Both SPIROMICS and COPDGene
32. Residential Segregation and COPD-Related Health Outcomes in SPIROMICS
33. Fine-Mapping of Bronchodilator Response Admixture Mapping Peak to Identify Causal Drug Response Genetic Variants
34. Genome-Wide Association Study of Acute Exacerbations of COPD Identifies Novel Loci in SPIROMICS
35. Genome-Wide Association Study of Sputum Mucin Concentrations in the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)
36. The Contribution of Individual and Neighborhood Factors to Racial Differences in COPD-Related Health Outcomes in SPIROMICS
37. Pathogenic Primary Ciliary Dyskinesia Pathway Variants Associate with Disease Severity in At-Risk Smokers and COPD Subjects from SPIROMICS
38. Genome-Wide Association Study Identifies Novel Loci and Recapitulates Known Loci for Interstitial Lung Disease in Non-Hispanic Whites from SPIROMICS
39. Disparities in Access to Food and COPD-Related Outcomes
40. The Rare PI Z Variant Associates with Bronchiectasis in Non-Hispanic White At-Risk Current and Ex-Smokers and COPD Subjects from SPIROMICS
41. Predictive Genetic Profiles for β-Agonist Therapy in Asthma. A Future under Construction
42. The Advent of High-Throughput Sequencing Studies of Chronic Obstructive Pulmonary Disease
43. Effects Of Rare ²2-Adrenergic Receptor Gene Variants And Long-Acting Beta Agonists On Healthcare Utilization And Corticosteroid Use In Two Multi-Ethnic Asthma Populations
44. Rare Beta2-Adrenergic Receptor Gene Polymorphisms In Asthma Cases And Controls From The Severe Asthma Research Program
45. Epigenetics Of The ²2-Adrenergic Receptor Gene
46. Characterization Of Asthma Cases And Controls With Rare ADAM33 Gene Polymorphisms In A Multi-Ethnic Population
47. Rare ²2 Adrenergic Receptor Gene Polymorphisms In Asthma Cases And Controls From Different Ethnic Groups
48. Methylation-Specific Sequencing of the β2 Adrenergic Receptor Gene in Asthma Cases and Controls
49. Characterization of Asthma Cases and Controls with Rareβ2Adrenergic Receptor Gene Polymorphisms in a Multi-Ethnic Population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.